Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Drug Safety|June 19, 2023
Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012-2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting RatePatrick E Beeler, Thomas Stammschulte, Holger DresselStudies in Health Technology and Informatics|August 12, 2015
Impact of Specific Alerts in Potassium-Increasing Drug-Drug InteractionsEmmanuel Eschmann, Patrick E Beeler, Jürg BlaserInternational Journal of Medical Informatics|August 25, 2019
Categorization of free-text drug orders using character-level recurrent neural networksYarden Raiskin, Carsten Eickhoff, Patrick E BeelerBritish Journal of Clinical Pharmacology|April 18, 2026
Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in SwitzerlandFiona A Strobel, Thomas Stammschulte, Patrick E BeelerStudies in Health Technology and Informatics|January 4, 2018
"Big Clinical Data" Analysis of Intravenous to Oral Conversions of Non-AntimicrobialsPatrick E Beeler, David W Bates, Jürg BlaserSwiss Medical Weekly|April 9, 2019
Negligible impact of highly patient-specific decision support for potassium-increasing drug-drug interactions - a cluster-randomised controlled trialPatrick E Beeler, Emmanuel Eschmann, Markus Schneemann, et al.The American Journal of Medicine|March 29, 2016
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart FailureJacques D Donzé, Patrick E Beeler, David W BatesStudies in Health Technology and Informatics|August 8, 2013
Evaluation of alerts for potassium-increasing drug-drug-interactionsEmmanuel Eschmann, Patrick E Beeler, Gregor Zünd, et al.International Journal of Medical Informatics|August 10, 2024
Enhancing communication and care coordination: A scoping review of encounter notification systems between emergency departments and primary care providersStaria Joseph, Rebecca Tomaschek, Balthasar L Hug, et al.Journal of Patient Safety|March 18, 2017
30-Day Potentially Avoidable Readmissions Due to Adverse Drug EventsOlivia Dalleur, Patrick E Beeler, Jeffrey L Schnipper, et al.Pageof 6